Assessment of non-standard HIV antiretroviral therapy regimens at Lighthouse Trust in Lilongwe, Malawi

about

Assessment of non-standard HIV antiretroviral therapy regimens at Lighthouse Trust in Lilongwe, Malawi

Item

http://www.wikidata.org/entity/Q36893580

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Assessment of non-standard HIV ...... ouse Trust in Lilongwe, Malawi

@en

type

Item

label

Assessment of non-standard HIV ...... ouse Trust in Lilongwe, Malawi

@en

prefLabel

Assessment of non-standard HIV ...... ouse Trust in Lilongwe, Malawi

@en

P1476

Assessment of non-standard HIV ...... ouse Trust in Lilongwe, Malawi

@en

P2093

B S Barnett

http://www.w3.org/2001/XMLSchema#string

H Tweya

http://www.w3.org/2001/XMLSchema#string

M C Hosseinipour

http://www.w3.org/2001/XMLSchema#string

S Phiri

http://www.w3.org/2001/XMLSchema#string

T Chaweza

http://www.w3.org/2001/XMLSchema#string

W Ngambi

http://www.w3.org/2001/XMLSchema#string

P2860

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

Antiretroviral drug supply challenges in the era of scaling up ART in Malawi

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

Pure red cell aplasia induced by lamivudine without the influence of zidovudine in a patient infected with human immunodeficiency virus.

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (

P304

6-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4314/MMJ.V28I1.2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217910

http://www.w3.org/2001/XMLSchema#string

P921

An Mhaláiv

P932

4864385

http://www.w3.org/2001/XMLSchema#string